Balasa Dinverno & Foltz LLC Amgen Inc Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Amgen Inc stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 5,812 shares of AMGN stock, worth $1.87 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,812
Previous 6,270
7.3%
Holding current value
$1.87 Million
Previous $1.53 Million
14.1%
% of portfolio
0.08%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding AMGN
# of Institutions
3,055Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.7 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.33 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.66 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.63 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...